Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
Sickle cell disease (SCD) is the most common inherited disease. Pain is a key morbidity of SCD and opioids are the main treatment but their side effects emphasize the need for new analgesic approaches. Humanized transgenic mouse models have been instructive in understanding the pathobiology of SCD...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Ferrata Storti Foundation
2022-05-01
|
| Серія: | Haematologica |
| Онлайн доступ: | https://haematologica.org/article/view/10659 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|